Therapeutics News and Research

RSS

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau's [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.

25 Mar 2019

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer's disease.

22 Mar 2019

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

Spontaneous preterm birth, defined as birth before 37 weeks of gestation, and the related complications, are the largest contributors to infant death in the United States and worldwide, according to the World Health Organization.

22 Mar 2019

Hidden differences between pathology of CTE and Alzheimer's disease discovered

An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer's disease and Chronic Traumatic Encephalopathy have identical pathology.

22 Mar 2019

Creating diverse pool of trained scientists to address Alzheimer's research needs

Roberta Diaz Brinton, PhD, an internationally recognized expert on Alzheimer's disease and inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has received a five-year, $1.8 million grant from the National Institutes of Health Institute on Aging.

22 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Innovative membrane offers a viable solution for periodontitis

Periodontitis affects nearly half of Americans ages 30 and older, and in its advanced stages, it could lead to early tooth loss or worse.

22 Mar 2019

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year's American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 - April 3, 2019.

22 Mar 2019

Certain bacteria and immune factors in vagina may cause or protect against preterm birth

Seven types of bacteria and certain immune factors in a woman's vagina and cervix may be responsible for increasing the risk of spontaneous preterm birth or protect against it, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and the University of Maryland School of Medicine.

22 Mar 2019

Role of immunological imprinting in elicitation of new antibodies

We are repeatedly exposed to the influenza virus via infections, vaccinations and our communal environments. The annual flu shot is believed to be the best line of defense, and doctors recommend vaccinations every year because the flu virus is in a constant state of adaptation and mutation, rendering older vaccines obsolete.

21 Mar 2019

MIT announces creation of the Alana Down Syndrome Center

As part of MIT's continued mission to help build a better world, the Institute announced the creation of the Alana Down Syndrome Center, an innovative new research endeavor, technology development initiative, and fellowship program launched with a $28.6 million gift from Alana Foundation, a nonprofit organization started by Ana Lucia Villela of São Paulo, Brazil.

21 Mar 2019

FDA approves brexanolone, first drug developed to treat postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention.

21 Mar 2019

First postpartum depression drug gets FDA nod

Sage therapeutics’ Zulresso became the first drug approved for postpartum depression by the United States Food and Drugs Administration (FDA). This cause the shares of Sage to rise by over 5 percent on Tuesday this week.

20 Mar 2019

Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease

Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety.

20 Mar 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

New analysis reveals precision oncology insights for colorectal cancer

Next-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to different survival and treatment outcomes in an analysis led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher.

20 Mar 2019

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

20 Mar 2019

Researchers identify origin of chronic pain in humans

A new study by researchers at The University of Texas at Dallas, UT MD Anderson Cancer Center, UT Health Science Center at Houston and Baylor College of Medicine has produced evidence of the source of chronic pain in humans, revealing several new targets for pain treatment.

19 Mar 2019

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Sweat shows promise for noninvasive health monitoring

Making a revolutionary biosensor takes blood, sweat and tears. And saliva, naturally.

15 Mar 2019

Therapeutics News and Research

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Exploring pathophysiological factors that link sleep problems and Alzheimer's disease

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

Hidden differences between pathology of CTE and Alzheimer's disease discovered

Creating diverse pool of trained scientists to address Alzheimer's research needs

City of Hope exhibits current studies and data on cancer therapies at AACR

Innovative membrane offers a viable solution for periodontitis

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Certain bacteria and immune factors in vagina may cause or protect against preterm birth

Role of immunological imprinting in elicitation of new antibodies

MIT announces creation of the Alana Down Syndrome Center

FDA approves brexanolone, first drug developed to treat postpartum depression

First postpartum depression drug gets FDA nod

Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease

Sphingotec reports new applications of bio-ADM at 39th ISICEM

New analysis reveals precision oncology insights for colorectal cancer

FDA approves first drug for treatment of postpartum depression in adult women

Researchers identify origin of chronic pain in humans

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Sweat shows promise for noninvasive health monitoring

Industry Focus eBook - Microbiome (1st edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News